China Universal Asset Management Co., Ltd. Taysha Gene Therapies, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.23 Billion
- Q4 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 44,635 shares of TSHA stock, worth $187,913. This represents 0.02% of its overall portfolio holdings.
Number of Shares
44,635
Previous 47,817
6.65%
Holding current value
$187,913
Previous $150,000
24.67%
% of portfolio
0.02%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding TSHA
# of Institutions
173Shares Held
250MCall Options Held
463KPut Options Held
246K-
Rtw Investments, LP New York, NY24.4MShares$103 Million1.03% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$99.2 Million1.27% of portfolio
-
Avoro Capital Advisors LLC New York, NY21.7MShares$91.4 Million0.93% of portfolio
-
Morgan Stanley New York, NY19.3MShares$81.3 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY13.4MShares$56.3 Million0.01% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $204M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...